$3.400
+0.030 (+0.89%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CANF Prediction & Forecast by Similar Chart Analysis
Alphio's CANF stock price prediction model matches the current Can Fite Biopharma Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.38 (-0.52%). The 1-week path is $3.36 (-1.12%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Can Fite Biopharma Ltd Stock?
Can Fite Biopharma Ltd (CANF) is a good buy right now due to its current trading price of $3.40, which is significantly below the analyst price target of $8, suggesting a potential upside of 135%. Additionally, the stock has shown a positive trend with a 5-day change of +2.10% and a 20-day change of +7.94%. The main risk is its negative earnings per share (EPS) forecast of -10.86 for Q4 2024, indicating ongoing financial challenges.
CANF stock price ended at $3.40 on Friday, after rising +0.89%
Can Fite Biopharma Ltd (CANF) last closed at $3.4, gaining +0.89%. These facts feed the 1-day and 1-week CANF price prediction above.
Analyst Consensus
Can Fite Biopharma Ltd (CANF): 2 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Can Fite Biopharma Ltd (CANF) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CANF, ranked by similarity.
Seasonality analysis for CANF
Historically the probability of a positive August return for CANF is 34.92%. March offers the highest probability of a positive month at 41.27%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.